{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:08:01Z","timestamp":1648966081588},"reference-count":8,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2009]]},"DOI":"10.2169\/naika.98.141","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T22:31:47Z","timestamp":1343773907000},"page":"141-143","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Mastocytosis with Coagulation Abnormalities and Gastrointestinal Symptoms"],"prefix":"10.2169","volume":"98","author":[{"given":"Kazuei","family":"Ogawa","sequence":"first","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Akutsu","sequence":"additional","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Shichishima","sequence":"additional","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyoshi","family":"Noji","sequence":"additional","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Mashita","sequence":"additional","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[{"name":"The First Departments of Internal Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Pathology, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1) Jaffe WS, et al: World health organization classification of tumors: Pathology and genetics, tumor of hematopoietic and lymphoid tissues. IARC Press, Lyon, 2001, 292-302."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Valent P, et al: Diagnostic criteria and classification of mastocytosis. A consensus proposal. Leuk Res 25: 603-625, 2001.","DOI":"10.1016\/S0145-2126(01)00038-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Valent P, et al: Diagnosis and treatment of systemic mastocytosis. State of the art. Br J Haematol 122: 695-717, 2003.","DOI":"10.1046\/j.1365-2141.2003.04575.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Metcalfe DD: Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 96: 2S-4S, 1991.","DOI":"10.1111\/1523-1747.ep12468882"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hansen U, et al: Shock and coagulation disorders in systemic mastocytosis. Dtsch Med Wochenschr 119: 1231-1234, 1994.","DOI":"10.1055\/s-2008-1058826"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Pardanani A: Systemic mastocytosis: bone marrow pathology, classification, and current therapies. Acta Haematol 114: 41-51, 2005.","DOI":"10.1159\/000085561"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Florian S, et al: Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesion, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 136: 273-280, 2005.","DOI":"10.1159\/000083954"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Pardanani A, et al: Imatinib for systemic mast-cell disease. Lancet 362: 535-537, 2003.","DOI":"10.1016\/S0140-6736(03)14115-3"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/98\/1\/98_141\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:45:48Z","timestamp":1621442748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/98\/1\/98_141\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.98.141","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}